MSCI
Asker Healthcare Group AB (FRA: I88) reported strong Q2 2026 results with 24% adjusted EBITDA growth and a...
Article Summary
HOLD- Asker Healthcare Group AB (FRA: I88) reported strong Q2 2026 results with 24% adjusted EBITDA growth and a 10% EbitDA margin, with net sales up 18% to $4.7 billion and organic growth of 6%, with MSCI receiving an AAA rating from MSCI for ESG and sustainability efforts.
- The company has completed four acquisitions year-to-date and is ahead of its annual targets, but leverage remains elevated at 2.37 times due to large cash outflows and a temporary increase in working capital due to double inventory costs related to a new warehouse in Gothenburg.
- Organic growth in the West region was lower than expected due to a strong prior year comparison, and the company discontinued an acquisition in Denmark due to prolonged competition authority processes.
- Earn-out payments for 2027 are expected to be larger than expected, though the ceiling on maximum payments remains intact.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 10.9% | 25% | 50.0 ptsMeets Minimum (10.9%) - Passes screener |
| EPS Growth Next 5Y ? | 14.8% | 25% | 35.0 ptsBelow Screener (14.8%) - Modest outlook |
| Target Price Upside ? | 26.1% | 20% | 75.0 ptsSignificant Upside (26.1%) - Target: $713.33 vs Current: $565.53 |
| Gross Margin % ? | 76.9% | 15% | 100.0 ptsExceptional (76.9%) - Strong pricing power |
| Drawdown from 52-Wk High ? | -12.3% | 15% | 40.0 ptsMild Pullback (-12.3%) - Light entry opportunity |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About MSCI
- MSCI Inc., together with its subsidiaries, provides research-based data, analytics, and indexes, supported by advanced technology worldwide.
- The Index segment provides indexes for use in various areas of the investment process, including indexed financial products, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.
- The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments.
- The Sustainability and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to assist investors navigate increasing regulation.
- The All Other – Private Assets segment comprises private credit, real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital.
- The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investment.
- MSCI Inc. was incorporated in 1998 and is based in New York, New York.